Institution
Universidade Federal do Espírito Santo
Education•Vitória, Brazil•
About: Universidade Federal do Espírito Santo is a education organization based out in Vitória, Brazil. It is known for research contribution in the topics: Population & Context (language use). The organization has 11411 authors who have published 17871 publications receiving 178098 citations.
Topics: Population, Context (language use), Dark energy, Blood pressure, Ontology (information science)
Papers published on a yearly basis
Papers
More filters
••
Heidelberg University1, Korea Institute for Advanced Study2, University of Nottingham3, Institute of Cosmology and Gravitation, University of Portsmouth4, University of Oxford5, Istituto Nazionale di Fisica Nucleare6, University of Bologna7, INAF8, University of Padua9, University of Toulouse10, University of Geneva11, University of Trieste12, Roma Tre University13, University of Milan14, University of Oslo15, Federal University of Rio Grande do Norte16, University College London17, Imperial College London18, Ludwig Maximilian University of Munich19, Autonomous University of Madrid20, ETH Zurich21, University of Edinburgh22, Leiden University23, Sun Yat-sen University24, Max Planck Society25, Royal Institute of Technology26, University of Milano-Bicocca27, University of California, Berkeley28, University of Pennsylvania29, Universidade Federal do Espírito Santo30, University of Porto31, University of Portsmouth32, King's College London33, Durham University34, Institut d'Astrophysique de Paris35, Helsinki Institute of Physics36, University of Lisbon37, Université Paris-Saclay38, Paris Diderot University39, University of Surrey40, University of Trento41, University of Chile42, Academy of Sciences of the Czech Republic43, University of Cyprus44, University of Barcelona45, California Institute of Technology46, Perimeter Institute for Theoretical Physics47
TL;DR: Euclid is a European Space Agency medium-class mission selected for launch in 2020 within the cosmic vision 2015-2025 program as discussed by the authors, which will explore the expansion history of the universe and the evolution of cosmic structures by measuring shapes and red-shift of galaxies as well as the distribution of clusters of galaxies over a large fraction of the sky.
Abstract: Euclid is a European Space Agency medium-class mission selected for launch in 2020 within the cosmic vision 2015–2025 program. The main goal of Euclid is to understand the origin of the accelerated expansion of the universe. Euclid will explore the expansion history of the universe and the evolution of cosmic structures by measuring shapes and red-shifts of galaxies as well as the distribution of clusters of galaxies over a large fraction of the sky. Although the main driver for Euclid is the nature of dark energy, Euclid science covers a vast range of topics, from cosmology to galaxy evolution to planetary research. In this review we focus on cosmology and fundamental physics, with a strong emphasis on science beyond the current standard models. We discuss five broad topics: dark energy and modified gravity, dark matter, initial conditions, basic assumptions and questions of methodology in the data analysis. This review has been planned and carried out within Euclid’s Theory Working Group and is meant to provide a guide to the scientific themes that will underlie the activity of the group during the preparation of the Euclid mission.
1,211 citations
••
Harvard University1, University of Michigan2, Shire plc3, University of California, Davis4, Pompeu Fabra University5, Katholieke Universiteit Leuven6, Utrecht University7, EHESP8, Ulster University9, Pontifical Xavierian University10, University of Otago11, Universidade Federal do Espírito Santo12, Universidade Nova de Lisboa13
TL;DR: In this paper, a cross-national BED data was presented and compared with bulimia nervosa (BN) data in the World Health Organization (WHO) World Mental Health Surveys.
962 citations
••
TL;DR: Although the unexplained higher incidence of hospitalization for dengue in year 3 among children younger than 9 years of age needs to be carefully monitored during long-term follow-up, the risk among children 2 to 16 years ofAge was lower in the vaccine group than in the control group.
Abstract: BACKGROUND A candidate tetravalent dengue vaccine is being assessed in three clinical trials involving more than 35,000 children between the ages of 2 and 16 years in Asian– Pacific and Latin American countries. We report the results of long-term follow-up interim analyses and integrated efficacy analyses. METHODS We are assessing the incidence of hospitalization for virologically confirmed dengue as a surrogate safety end point during follow-up in years 3 to 6 of two phase 3 trials, CYD14 and CYD15, and a phase 2b trial, CYD23/57. We estimated vaccine efficacy using pooled data from the first 25 months of CYD14 and CYD15. RESULTS Follow-up data were available for 10,165 of 10,275 participants (99%) in CYD14 and 19,898 of 20,869 participants (95%) in CYD15. Data were available for 3203 of the 4002 participants (80%) in the CYD23 trial included in CYD57. During year 3 in the CYD14, CYD15, and CYD57 trials combined, hospitalization for virologically confirmed dengue occurred in 65 of 22,177 participants in the vaccine group and 39 of 11,089 participants in the control group. Pooled relative risks of hospitalization for dengue were 0.84 (95% confidence interval [CI], 0.56 to 1.24) among all participants, 1.58 (95% CI, 0.83 to 3.02) among those under the age of 9 years, and 0.50 (95% CI, 0.29 to 0.86) among those 9 years of age or older. During year 3, hospitalization for severe dengue, as defined by the independent data monitoring committee criteria, occurred in 18 of 22,177 participants in the vaccine group and 6 of 11,089 participants in the control group. Pooled rates of efficacy for symptomatic dengue during the first 25 months were 60.3% (95% CI, 55.7 to 64.5) for all participants, 65.6% (95% CI, 60.7 to 69.9) for those 9 years of age or older, and 44.6% (95% CI, 31.6 to 55.0) for those younger than 9 years of age. CONCLUSIONS Although the unexplained higher incidence of hospitalization for dengue in year 3 among children younger than 9 years of age needs to be carefully monitored during long-term follow-up, the risk among children 2 to 16 years of age was lower in the vaccine group than in the control group. (Funded by Sanofi Pasteur; ClinicalTrials .gov numbers, NCT00842530, NCT01983553, NCT01373281, and NCT01374516.)
831 citations
••
University of São Paulo1, St George's Hospital2, University of Otago3, Universidad Autónoma Metropolitana4, Stony Brook University5, Katholieke Universiteit Leuven6, Utrecht University7, University of Ibadan8, Peking University9, Harvard University10, Paris Descartes University11, Mental Health Services12, Leipzig University13, Ulster University14, Pontifical Xavierian University15, All India Institute of Medical Sciences16, University of Cape Town17, Universidade Federal do Espírito Santo18, Universidade Nova de Lisboa19
TL;DR: Low perceived need and attitudinal barriers are the major barriers to seeking and staying in treatment among individuals with common mental disorders worldwide.
Abstract: The WHO WMH Survey Initiative is supported by the National Institute of Mental Health (NIMH; R01 MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864 and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481). The Sao Paulo Megacity Mental Health Survey is supported by the State of Sao Paulo Research Foundation (FAPESP) Thematic Project Grant 03/00 204-3. The ESEMeD project is funded by the European Commission (Contracts QLG5-1999-01 042; SANCO 2 004 123 and EAHC20081308), the Piedmont Region (Italy), Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnologia, Spain (SAF 2000-158-CE), Departament de Salut, Generalitat de Catalunya, Spain, Instituto de Salud Carlos III (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP). The World Mental Health Japan (WMHJ) Survey is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013) from the Japan Ministry of Health, Labor and Welfare. The Lebanese National Mental Health Survey (LEBANON) is supported by the National Institute of Health/Fogarty International Center (R03 TW006481- 01. The Mexican National Comorbidity Survey (MNCS) is supported by The National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544-H). The Ukraine Comorbid Mental Disorders during Periods of Social Disruption (CMDPSD) study was funded by the US National Institute of Mental Health (RO1-MH61905). The US National Comorbidity Survey Replication (NCS-R) is supported by the NIMH (U01-MH60220), the Robert Wood Johnson Foundation (RWJF; Grant044780)
766 citations
••
Harvard University1, University of California, Davis2, Pompeu Fabra University3, Stony Brook University4, Universidade Nova de Lisboa5, National Drug and Alcohol Research Centre6, Centre for Mental Health7, University College Hospital, Ibadan8, University of Barcelona9, Peking University10, University of Balamand11, St George's Hospital12, University of Tokyo13, The Chinese University of Hong Kong14, Paris Descartes University15, Mental Health Services16, University of Michigan17, Cayetano Heredia University18, University of Otago19, University of Cape Town20, Center for Excellence in Education21, Universidade Federal do Espírito Santo22
TL;DR: Although a substantial minority of PTSD cases remits within months after onset, mean symptom duration is considerably longer than previously recognized and differential across trauma types with respect to PTSD risk.
Abstract: Background: Although post-traumatic stress disorder (PTSD) onset-persistence is thought to vary significantly by trauma type, most epidemiological surveys are incapable of assessing this because they evaluate lifetime PTSD only for traumas nominated by respondents as their 'worst.' Objective: To review research on associations of trauma type with PTSD in the WHO World Mental Health (WMH) surveys, a series of epidemiological surveys that obtained representative data on trauma-specific PTSD. Method: WMH Surveys in 24 countries (n = 68,894) assessed 29 lifetime traumas and evaluated PTSD twice for each respondent: once for the 'worst' lifetime trauma and separately for a randomly-selected trauma with weighting to adjust for individual differences in trauma exposures. PTSD onset-persistence was evaluated with the WHO Composite International Diagnostic Interview. Results: In total, 70.4% of respondents experienced lifetime traumas, with exposure averaging 3.2 traumas per capita. Substantial between-trauma differences were found in PTSD onset but less in persistence. Traumas involving interpersonal violence had highest risk. Burden of PTSD, determined by multiplying trauma prevalence by trauma-specific PTSD risk and persistence, was 77.7 person-years/100 respondents. The trauma types with highest proportions of this burden were rape (13.1%), other sexual assault (15.1%), being stalked (9.8%), and unexpected death of a loved one (11.6%). The first three of these four represent relatively uncommon traumas with high PTSD risk and the last a very common trauma with low PTSD risk. The broad category of intimate partner sexual violence accounted for nearly 42.7% of all person-years with PTSD. Prior trauma history predicted both future trauma exposure and future PTSD risk. Conclusions: Trauma exposure is common throughout the world, unequally distributed, and differential across trauma types with respect to PTSD risk. Although a substantial minority of PTSD cases remits within months after onset, mean symptom duration is considerably longer than previously recognized.
739 citations
Authors
Showing all 11542 results
Name | H-index | Papers | Citations |
---|---|---|---|
James Taylor | 95 | 1161 | 39945 |
Paulo A. Lotufo | 89 | 622 | 100527 |
Tian Li Wang | 73 | 274 | 22717 |
Jochen Autschbach | 69 | 396 | 16880 |
E. M. Santos | 68 | 250 | 18876 |
José Eduardo Krieger | 61 | 505 | 16300 |
Mark E. Smith | 59 | 419 | 13202 |
Antonio Luiz Pinho Ribeiro | 59 | 533 | 55679 |
Marcus Lira Brandão | 54 | 243 | 9248 |
Andre R. Brunoni | 54 | 349 | 14772 |
John L. Johnson | 52 | 201 | 8445 |
António J. C. Varandas | 49 | 396 | 9535 |
Mercedes Salaices | 47 | 220 | 6474 |
Karen B. Strier | 46 | 148 | 6497 |
Maria Carmen Viana | 46 | 166 | 13725 |